Zurich, Switzerland

Gregor Welti

This inventor holds 1 USPTO granted patent. Top assignee: Biocryst Pharmaceuticals, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregor Welti. Retrieved from https://idiyas.com/inventor/gregor-welti-7f7esfri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gregor Welti

Introduction

Gregor Welti is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to the filing of a patent that showcases his innovative approach to chemical processes.

Latest Patents

Gregor Welti holds a patent for a process titled "Process for preparing (-)-(1S, 4R) N-protected 4-amino-2-cyclopentene-1-carboxylate esters." This patent reflects his expertise in organic chemistry and his commitment to advancing the field through innovative methodologies. He has 1 patent to his name, demonstrating his capability as an inventor.

Career Highlights

Welti is currently employed at Biocryst Pharmaceuticals, Inc., where he applies his knowledge and skills to develop pharmaceutical solutions. His role at the company allows him to work on cutting-edge projects that aim to improve health outcomes through innovative drug development.

Collaborations

Throughout his career, Gregor has collaborated with esteemed colleagues, including Cynthia Anne Maryanoff and Max Rey. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Gregor Welti's contributions to the field of chemistry and his innovative spirit are evident through his patent and work at Biocryst Pharmaceuticals, Inc. His collaborations with other professionals further highlight his commitment to advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…